Krutmann J - Search Results

1

Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma.

Plettenberg H, Stege H, Megahed M, Ruzicka T, Hosokawa Y, Tsuji T, Morita A, Krutmann J. Plettenberg H, et al. Among authors: krutmann j. J Am Acad Dermatol. 1999 Jul;41(1):47-50. doi: 10.1016/s0190-9622(99)70405-6. J Am Acad Dermatol. 1999. PMID: 10411410

2

High-dose UVA1 therapy in the treatment of patients with atopic dermatitis.

Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E. Krutmann J, et al. J Am Acad Dermatol. 1992 Feb;26(2 Pt 1):225-30. doi: 10.1016/0190-9622(92)70031-a. J Am Acad Dermatol. 1992. PMID: 1552057 Clinical Trial.

3

Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet A1 radiation.

Grewe M, Gyufko K, Krutmann J. Grewe M, et al. Among authors: krutmann j. J Invest Dermatol. 1995 Jan;104(1):3-6. doi: 10.1111/1523-1747.ep12613446. J Invest Dermatol. 1995. PMID: 7798637 Free article.

4

Evidence that DNA damage is a mediate in ultraviolet B radiation-induced inhibition of human gene expression: ultraviolet B radiation effects on intercellular adhesion molecule-1 (ICAM-1) expression.

Krutmann J, Bohnert E, Jung EG. Krutmann J, et al. J Invest Dermatol. 1994 Apr;102(4):428-32. doi: 10.1111/1523-1747.ep12372947. J Invest Dermatol. 1994. PMID: 7908681 Free article.

5

High-dose UVA1 for urticaria pigmentosa.

Stege H, Schöpf E, Ruzicka T, Krutmann J. Stege H, et al. Among authors: krutmann j. Lancet. 1996 Jan 6;347(8993):64. doi: 10.1016/s0140-6736(96)91600-1. Lancet. 1996. PMID: 8531579 No abstract available.

6

Coagulation factor V gene mutation associated with activated protein C resistance leading to recurrent thrombosis, leg ulcers, and lymphedema: successful treatment with intermittent compression.

Peus D, von Schmiedeberg S, Pier A, Scharf RE, Wehmeier A, Ruzicka T, Krutmann J. Peus D, et al. Among authors: krutmann j. J Am Acad Dermatol. 1996 Aug;35(2 Pt 2):306-9. doi: 10.1016/s0190-9622(96)90655-6. J Am Acad Dermatol. 1996. PMID: 8698912

7

High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema.

Grabbe J, Welker P, Humke S, Grewe M, Schöpf E, Henz BM, Krutmann J. Grabbe J, et al. Among authors: krutmann j. J Invest Dermatol. 1996 Sep;107(3):419-22. doi: 10.1111/1523-1747.ep12363402. J Invest Dermatol. 1996. PMID: 8751980 Free article.

8

[Nicotinamide administration to patients with "sunlight allergy"].

Stege H, Krutmann J. Stege H, et al. Among authors: krutmann j. Hautarzt. 1996 Jun;47(6):472. doi: 10.1007/s001050050455. Hautarzt. 1996. PMID: 8767666 German. No abstract available.

9

Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation.

Grewe M, Gyufko K, Budnik A, Ruzicka T, Olaizola-Horn S, Berneburg M, Krutmann J. Grewe M, et al. Among authors: krutmann j. J Invest Dermatol. 1996 Dec;107(6):865-70. J Invest Dermatol. 1996. PMID: 8941676

10

Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis.

Werfel T, Morita A, Grewe M, Renz H, Wahn U, Krutmann J, Kapp A. Werfel T, et al. Among authors: krutmann j. J Invest Dermatol. 1996 Dec;107(6):871-6. doi: 10.1111/1523-1747.ep12331164. J Invest Dermatol. 1996. PMID: 8941677 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

412 results

Search Page

Filters